Increased glucose-dependent insulinotropic polypeptide (GIP) secretion in acromegaly

M. Peracchi, S. Porretti, C. Gebbia, C. Pagliari, P. Bucciarelli, P. Epaminonda, S. Manenti, M. Arosio

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: Acromegaly is often associated with fasting and postprandial hyperinsulinemia, and the mechanisms involved are only partly understood. Hypersecretion of incretins such as glucose-dependent insulinotropic polypeptide (GIP) could play a role in determining hyperinsulinemia in acromegaly, but the available data are inconsistent. The aim of this study was to characterize the fasting and postprandial pattern of plasma GIP and insulin in a group of acromegalic patients. Design and Methods: Eleven non-diabetic patients with newly diagnosed acromegaly and 11 sex- and age-matched healthy subjects were studied. Blood samples were taken at regular intervals in fasting conditions and for 3 h after a standard solid-liquid meal for growth hormone (GH), GIP and insulin measurements. Results: Not only insulin, but also fasting and postprandial GIP levels were significantly higher in the patients with acromegaly than the healthy subjects (P <0.01). In the former group fasting GIP levels and the integrated GIP response to the meal correlated significantly with GH basal levels (r = 0.83, P <0.01 and r = 0.65, P <0.05, respectively). Moreover, multivariate linear regression analysis showed that the presence of acromegalic status was associated with higher fasting and postprandial GIP levels independently of sex, age, fasting and postprandial plasma glucose and insulin levels, and the occurrence of normal or impaired glucose tolerance. Conclusion: This study provides evidence that in patients with acromegaly fasting and postprandial GIP levels are abnormally high. GIP hypersecretion in turn might play a role in the pathogenesis of hyperinsulinemia that characterizes acromegaly.

Original languageEnglish
JournalEuropean Journal of Endocrinology
Volume145
Issue number1
Publication statusPublished - 2001

Fingerprint

Acromegaly
Fasting
Glucose
Peptides
Hyperinsulinism
Insulin
Growth Hormone
Meals
Healthy Volunteers
Incretins
Glucose Intolerance
Linear Models
Regression Analysis

ASJC Scopus subject areas

  • Endocrinology

Cite this

Increased glucose-dependent insulinotropic polypeptide (GIP) secretion in acromegaly. / Peracchi, M.; Porretti, S.; Gebbia, C.; Pagliari, C.; Bucciarelli, P.; Epaminonda, P.; Manenti, S.; Arosio, M.

In: European Journal of Endocrinology, Vol. 145, No. 1, 2001.

Research output: Contribution to journalArticle

Peracchi, M, Porretti, S, Gebbia, C, Pagliari, C, Bucciarelli, P, Epaminonda, P, Manenti, S & Arosio, M 2001, 'Increased glucose-dependent insulinotropic polypeptide (GIP) secretion in acromegaly', European Journal of Endocrinology, vol. 145, no. 1.
Peracchi, M. ; Porretti, S. ; Gebbia, C. ; Pagliari, C. ; Bucciarelli, P. ; Epaminonda, P. ; Manenti, S. ; Arosio, M. / Increased glucose-dependent insulinotropic polypeptide (GIP) secretion in acromegaly. In: European Journal of Endocrinology. 2001 ; Vol. 145, No. 1.
@article{306ba66f246349f9825f05291a145b4b,
title = "Increased glucose-dependent insulinotropic polypeptide (GIP) secretion in acromegaly",
abstract = "Objective: Acromegaly is often associated with fasting and postprandial hyperinsulinemia, and the mechanisms involved are only partly understood. Hypersecretion of incretins such as glucose-dependent insulinotropic polypeptide (GIP) could play a role in determining hyperinsulinemia in acromegaly, but the available data are inconsistent. The aim of this study was to characterize the fasting and postprandial pattern of plasma GIP and insulin in a group of acromegalic patients. Design and Methods: Eleven non-diabetic patients with newly diagnosed acromegaly and 11 sex- and age-matched healthy subjects were studied. Blood samples were taken at regular intervals in fasting conditions and for 3 h after a standard solid-liquid meal for growth hormone (GH), GIP and insulin measurements. Results: Not only insulin, but also fasting and postprandial GIP levels were significantly higher in the patients with acromegaly than the healthy subjects (P <0.01). In the former group fasting GIP levels and the integrated GIP response to the meal correlated significantly with GH basal levels (r = 0.83, P <0.01 and r = 0.65, P <0.05, respectively). Moreover, multivariate linear regression analysis showed that the presence of acromegalic status was associated with higher fasting and postprandial GIP levels independently of sex, age, fasting and postprandial plasma glucose and insulin levels, and the occurrence of normal or impaired glucose tolerance. Conclusion: This study provides evidence that in patients with acromegaly fasting and postprandial GIP levels are abnormally high. GIP hypersecretion in turn might play a role in the pathogenesis of hyperinsulinemia that characterizes acromegaly.",
author = "M. Peracchi and S. Porretti and C. Gebbia and C. Pagliari and P. Bucciarelli and P. Epaminonda and S. Manenti and M. Arosio",
year = "2001",
language = "English",
volume = "145",
journal = "European Journal of Endocrinology",
issn = "0804-4643",
publisher = "BioScientifica Ltd.",
number = "1",

}

TY - JOUR

T1 - Increased glucose-dependent insulinotropic polypeptide (GIP) secretion in acromegaly

AU - Peracchi, M.

AU - Porretti, S.

AU - Gebbia, C.

AU - Pagliari, C.

AU - Bucciarelli, P.

AU - Epaminonda, P.

AU - Manenti, S.

AU - Arosio, M.

PY - 2001

Y1 - 2001

N2 - Objective: Acromegaly is often associated with fasting and postprandial hyperinsulinemia, and the mechanisms involved are only partly understood. Hypersecretion of incretins such as glucose-dependent insulinotropic polypeptide (GIP) could play a role in determining hyperinsulinemia in acromegaly, but the available data are inconsistent. The aim of this study was to characterize the fasting and postprandial pattern of plasma GIP and insulin in a group of acromegalic patients. Design and Methods: Eleven non-diabetic patients with newly diagnosed acromegaly and 11 sex- and age-matched healthy subjects were studied. Blood samples were taken at regular intervals in fasting conditions and for 3 h after a standard solid-liquid meal for growth hormone (GH), GIP and insulin measurements. Results: Not only insulin, but also fasting and postprandial GIP levels were significantly higher in the patients with acromegaly than the healthy subjects (P <0.01). In the former group fasting GIP levels and the integrated GIP response to the meal correlated significantly with GH basal levels (r = 0.83, P <0.01 and r = 0.65, P <0.05, respectively). Moreover, multivariate linear regression analysis showed that the presence of acromegalic status was associated with higher fasting and postprandial GIP levels independently of sex, age, fasting and postprandial plasma glucose and insulin levels, and the occurrence of normal or impaired glucose tolerance. Conclusion: This study provides evidence that in patients with acromegaly fasting and postprandial GIP levels are abnormally high. GIP hypersecretion in turn might play a role in the pathogenesis of hyperinsulinemia that characterizes acromegaly.

AB - Objective: Acromegaly is often associated with fasting and postprandial hyperinsulinemia, and the mechanisms involved are only partly understood. Hypersecretion of incretins such as glucose-dependent insulinotropic polypeptide (GIP) could play a role in determining hyperinsulinemia in acromegaly, but the available data are inconsistent. The aim of this study was to characterize the fasting and postprandial pattern of plasma GIP and insulin in a group of acromegalic patients. Design and Methods: Eleven non-diabetic patients with newly diagnosed acromegaly and 11 sex- and age-matched healthy subjects were studied. Blood samples were taken at regular intervals in fasting conditions and for 3 h after a standard solid-liquid meal for growth hormone (GH), GIP and insulin measurements. Results: Not only insulin, but also fasting and postprandial GIP levels were significantly higher in the patients with acromegaly than the healthy subjects (P <0.01). In the former group fasting GIP levels and the integrated GIP response to the meal correlated significantly with GH basal levels (r = 0.83, P <0.01 and r = 0.65, P <0.05, respectively). Moreover, multivariate linear regression analysis showed that the presence of acromegalic status was associated with higher fasting and postprandial GIP levels independently of sex, age, fasting and postprandial plasma glucose and insulin levels, and the occurrence of normal or impaired glucose tolerance. Conclusion: This study provides evidence that in patients with acromegaly fasting and postprandial GIP levels are abnormally high. GIP hypersecretion in turn might play a role in the pathogenesis of hyperinsulinemia that characterizes acromegaly.

UR - http://www.scopus.com/inward/record.url?scp=0034918760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034918760&partnerID=8YFLogxK

M3 - Article

C2 - 11415859

AN - SCOPUS:0034918760

VL - 145

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

SN - 0804-4643

IS - 1

ER -